Read more

January 18, 2022
3 min watch
Save

VIDEO: Pegcetacoplan shows significant growth reduction in eyes with geographic atrophy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WAIKOLOA, Hawaii — In this video from Retina 2022, Caroline R. Baumal, MD, discusses the phase 3 DERBY and OAKS studies investigating pegcetacoplan in patients with geographic atrophy.